Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The largest U.S. airline United Continental Holdings Inc. (UAL - Analyst Report) estimates weak traffic in the third quarter on concerns over travel demand and pricing. The company expects passenger revenue per available seat mile (PRASM or unit revenue) to decline 1-2% in the third quarter. This compares with unit revenue growth of 9.2% in the year-ago quarter.
This expectation came in just few weeks after the company reduced its flying capacity outlook through rest of the year owing to the higher fuel prices and sluggish economy. United is reducing its capacity by reducing flight frequencies, indefinitely postponing flights to certain markets and exiting less profitable markets.
United now expects consolidated capacity to fall 1.4% year over year in the third quarter. This is up from the 0.7-1.7% decline projected by the company in the second quarter earnings call.
Consolidated unit cost, excluding fuel, third-party business expense and special items, is estimated to grow 2.8-3.8% year over year, down from 3-4% projected previously. The company now estimates fuel price to be $3.18 per gallon for the ongoing quarter, up from the previous forecast of $3.13 per gallon.
For the third quarter, the Zacks Consensus Estimate for United is pegged at $1.80, down 2 cents over the last week and 15 cents over the last month. The estimate represents a decline of 8.71% annually.
Further, United Continental, which competes strongly with Delta Air Lines Inc. (DAL - Analyst Report) and Southwest Airlines Co. (LUV - Analyst Report), continues to have a healthy balance sheet. The company expects to exit the quarter with $6.6 billion in unrestricted liquidity including cash and short-term investments.
We currently have an Underperform recommendation on United Continental. For the short term (1-3 months), the stock also retains a Zacks #5 (Strong Sell) Rank.
Get the full Analyst Report on LUV - FREE
Get the full Analyst Report on DAL - FREE
Get the full Analyst Report on UAL - FREE